Scholars at Sant Gadge Baba Amravati University (AU) have achieved a high scientific milestone by being internationally patented by the South African government. This recognition was awarded due to the creation of an innovative technology capable of minimally shortening the time that it took to test the efficiency of antibiotics. The discovery, which was based on the Biotechnology and Microbiology sectors of the university, is a significant breakthrough in the sphere of medical diagnostics and individual care.
Innovation and legacy
Professor Dr. Prashant Thakare and Dr. Neeraj Ghanvate headed the research team of this innovation and were assisted by a dedicated researcher, Pooja Mandaviya. They came up with a special kit that could be used to quickly detect the minimum inhibitory concentration (MIC) of a particular antibiotic on a certain bacterial species. MIC is a vital medical measure that defines the minimum concentration of an antibiotic at which a microorganism cannot grow visibly. The technology enables medical care providers to find the most effective treatments to help patients faster and more accurately by delivering such outcomes much faster than other conventional techniques.
This is the third patent that has been registered by Dr. Thakare and Dr. Ghanvate, which further reinforces the reputation that the two experts have regarding research excellence. The duo has a history of a long time of serving the public health and scientific infrastructure. They have played a crucial role in the development of the Molecular Diagnosis Lab in Amravati at the peak of the COVID-19 crisis, one that became an important part of the local diagnostic work. Their high production of quality research at the higher levels has kept Amravati University on the international scientific map.
Impact of the work
The work has an overall effect that goes beyond the patent. Their study was recently recognized by the team in a global conference in Hyderabad, as the team was awarded by the rest of the world’s scientific community. After the South African patent was announced, the officials at the university became extremely proud of the success of the team. They recognized the patent as definite evidence of the increased research strength of the institution and the possibilities to create innovations that are of an international level.
The researchers were congratulated by the Vice-Chancellor of Sant Gadge Baba Amravati University, Milind Barhate, who also emphasized the larger consequences of this achievement. He said he was very positive that such a milestone is something to build on in coming up with new milestones. The Vice-Chancellor claims that these victories solidify the university as a centre of scientific excellence and will be what motivates others to do other groundbreaking studies within the different departments of the university.
Conclusion
The fact that the researchers of Amravati University have acquired a South African patent is a first in its history because it highlights the value of localized research with worldwide applications. This technology can serve as a solution to one of the current problems in modern medicine: finding prompt and precise diagnostic instruments by simplifying the procedure of antibiotic testing. This success remains a major contribution to the international quest to enhance healthcare performance with hi-tech biotechnology, as the university carries on with building an innovative environment.
Read the full article here